Next Article in Journal
Snakebite Clinics and Pathogenesis: From Preclinical to Resource Mapping Studies
Next Article in Special Issue
Preliminary Insights of Brazilian Snake Venom Metalloproteomics
Previous Article in Journal
An Occurrence and Exposure Assessment of Paralytic Shellfish Toxins from Shellfish in Zhejiang Province, China
Previous Article in Special Issue
Multilevel Comparison of Indian Naja Venoms and Their Cross-Reactivity with Indian Polyvalent Antivenoms
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxins
Volume 15
Issue 11
10.3390/toxins15110625
toxins-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action

by
Suzanne N. Serrath
1,
Adriana S. Pontes
1,
Mauro V. Paloschi
1,
Milena D. S. Silva
1,
Jéssica A. Lopes
1,
Charles N. Boeno
1,
Carolina P. Silva
1,
Hallison M. Santana
1,
Daniel G. Cardozo
1,
Andrey V. E. Ugarte
1,
João G. S. Magalhães
1,
Larissa F. Cruz
1,
Sulamita S. Setubal
1,
Andreimar M. Soares
2,
Bruna Cavecci-Mendonça
3,
Lucilene D. Santos
3,4 and
Juliana P. Zuliani
1,5,*
1
Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil
2
Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health (LABIOPROT), National Institute of Science and Technology in Epidemiology of the Occidental Amazonia0 (INCT-EPIAMO), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho 76801-059, RO, Brazil
3
Biotechonology Institute (IBTEC), São Paulo State University, Botucatu 01049-010, SP, Brazil
4
Graduate Program in Tropical Diseases and Graduate Program in Medical Biotechnology, Botucatu Medical School (FMB), São Paulo State University, Botucatu 18618-687, SP, Brazil
5
Departamento de Medicina, Universidade Federal de Rondônia, Porto Velho 76801-059, RO, Brazil
*
Author to whom correspondence should be addressed.
Toxins 2023, 15(11), 625; https://doi.org/10.3390/toxins15110625
Submission received: 31 August 2023 / Revised: 20 September 2023 / Accepted: 17 October 2023 / Published: 25 October 2023
(This article belongs to the Special Issue Proteomic Analysis and Functional Characterization of Venom)
Browse Figures
Review Reports Versions Notes

Abstract

:
L-Amino acid oxidase (LAAO) is an enzyme found in snake venom that has multifaceted effects, including the generation of hydrogen peroxide (H2O2) during oxidative reactions, leading to various biological and pharmacological outcomes such as apoptosis, cytotoxicity, modulation of platelet aggregation, hemorrhage, and neutrophil activation. Human neutrophils respond to LAAO by enhancing chemotaxis, and phagocytosis, and releasing reactive oxygen species (ROS) and pro-inflammatory mediators. Exosomes cellular nanovesicles play vital roles in intercellular communication, including immune responses. This study investigates the impact of Calloselasma rhodostoma snake venom-derived LAAO (Cr-LAAO) on human neutrophil exosome release, including activation patterns, exosome formation, and content. Neutrophils isolated from healthy donors were stimulated with Cr-LAAO (100 μg/mL) for 3 h, followed by exosome isolation and analysis. Results show that Cr-LAAO induces the release of exosomes with distinct protein content compared to the negative control. Proteomic analysis reveals proteins related to the regulation of immune responses and blood coagulation. This study uncovers Cr-LAAO’s ability to activate human neutrophils, leading to exosome release and facilitating intercellular communication, offering insights into potential therapeutic approaches for inflammatory and immunological disorders.
Keywords:
Cr-LAAO; extracellular vesicle; snake venom; inflammation
Key Contribution: Proteomic analysis unveils that exosomes released in response to Cr-LAAO contain proteins associated with the regulation of the immune response, implying that the action of this toxin may have implications in neutrophil-mediated inflammation in snake envenomation.

1. Introduction

L-Amino acid oxidase (LAAO) is an enzyme widely distributed in several species, such as insects, fungi, plants, and snake venoms [1,2,3,4,5]. The mechanism of action of LAAO is not yet fully elucidated but involves oxidative effects on various pathogens, such as fungi and viruses, as well as on various cell lines. Some of the observed effects are attributed to the production of hydrogen peroxide (H2O2) during oxidative reactions [6,7].
The literature demonstrates the biological and pharmacological effects induced by LAAO, including apoptosis induction [8], cytotoxicity [9], induction or inhibition of platelet aggregation [10], hemorrhage [11], hemolysis [12], bactericidal effects [13,14], leishmanicidal effects [15], edema [16], and activation of human neutrophils [17,18,19,20,21]. Many of the biological effects of LAAOs are attributed to the secondary effects of H2O2 produced during the enzymatic reaction [10,16,22,23].
The ability of LAAO to activate cells of the immune system, particularly human neutrophils, was reported by PONTES et al. [17,18] and PALOSCHI et al. [19,20,21] using an LAAO isolated from Calloselasma rhodostoma snake venom, named Cr-LAAO. This LAAO stimulates neutrophils chemotaxis, phagocytosis, production, and release of reactive oxygen species (ROS) through Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase complex activation, as well as the release of pro-inflammatory cytokines, myeloperoxidase, and lipid mediators. It also activates NLRP3 inflammasome [17,18,19,20,21].
The literature has demonstrated that Cr-LAAO is responsible for the activation of human neutrophils in vitro. This activation leads to the stimulation of the production of superoxide anion and H2O2 through the activation of NADPH oxidase. Additionally, it induces chemotaxis and phagocytosis [17,18,19]. Cr-LAAO also induces the activation of the corpuscle-dependent cyclooxygenase pathway lipids and cytosolic phospholipases A2, NLRP3 inflammasome, and the release of myeloperoxidase (MPO), interleukin 8 (IL-8), IL-6, IL-1β, tumor necrosis factor alpha (TNF-α), Leukotriene B4 (LTB4), Prostaglandin E2 (PGE2), and Neutrophil Extracellular Traps (NETs) [17,18,19,20,21]. Furthermore, it induces an acute response in vivo, as evidenced by leukocyte migration to the peritoneal cavity and the release of IL-6, IL-1β, LTB4, and PGE2 [24].
While leukocytes are implicated in several inflammatory pathologies, little is known about the state of activation of these cells during Cr-LAAO action. Recent research indicates that extracellular vesicles may be used by cells to transfer inflammatory mediators and receptors [25]. Majumdar et al. [26] demonstrated that these vesicles carry mediators such as LTB4, acting in an autocrine manner, sensitizing neutrophils, and amplifying the inflammatory response. Additionally, it was shown that these vesicles acted in a paracrine manner, promoting cell communication [27].
Exosomes, nanovesicles secreted by cells into the extracellular space, have an endocytic origin, and their size ranges from 40 to 100 nm in diameter [28]. Their formation occurs through the production of endocytic vesicles from the plasma membrane, called primitive endosomes. Subsequently, they become late endosomes, or multivesicular bodies (MVB), containing numerous intraluminal vesicles, which can be degraded by lysosomes or fuse with the cell plasma membrane, releasing their contents into the extracellular medium [29].
Through the interaction of exosomal membrane proteins with the target cell via juxtacrine communication, vesicles can initiate cell signaling events, activating the target cell [30]. Exosomes also hold potential as a novel therapeutic technique since they offer a method for delivering materials such as medicines, proteins, and siRNAs to specific cells or tissues through laboratory manipulation [31,32].
The ability to use exosomes as biomarkers, released under both normal and pathological conditions, has been demonstrated by the literature in various bodily fluids, including blood, tears, saliva, urine, and cerebrospinal fluid [33,34]. Recently, the importance of studying the intravesicular components of exosomes, such as proteins, mRNA, and miRNA, has been highlighted, as they are implicated in the progression of viral pathologies and their prognosis [35,36,37,38]. Moreover, its components can influence immuno-regulatory processes, such as tumor escape mechanisms, and regenerative and degenerative processes [39].
These vesicles are composed mainly of lipids and membrane proteins, similar to those present in the cell from which they originate. Furthermore, they may contain proteins and mRNA transcripts derived from the intracytoplasmic environment [40]. Their ability to interact with different cell types makes them an important mechanism for intercellular communication in the body. Furthermore, their role in the vascular environment depends on the cellular origin and the type of stimulus used to promote vesiculation, giving them specialized functions in their cellular targets [41,42].
The literature shows that exosomes are involved in cell–cell communication and can carry molecules such as MHC-II (linked to antigenic peptides), amplifying and modulating the immune response [43,44,45,46,47]. Additionally, exosomes are found in biological fluids such as plasma, bronchoalveolar lavage, breast milk, and saliva [48]. However, due to their small size and heterogeneity, detecting and classifying them remains a challenge [25]. Based on these considerations, studying the activation, formation, and release pattern of human neutrophil exosomes induced by Cr-LAAO may provide insights into their role in the inflammatory response and better characterize them for future clinical applications.

2. Results

The electrophoretic profile of exosome samples from RPMI (negative group), PMA (positive control group), and Cr-LAAO (experimental group) has revealed the presence of proteins at approximately 60 kDa under all conditions (Figure 1A). The size of the exosome vesicles present in the extracellular medium particles ranges from 8 to 70 nm for the negative control group, 6 to 50 nm for the positive control group, and 8 to 70 nm for the Cr-LAAO group (Figure 1B–D). Immunoreactivity of antibodies to CD63 and CD81 was detected in the samples of exosomes from neutrophils stimulated with Cr-LAAO, as well as in the negative control. However, cells stimulated with PMA did not exhibit immunoreactivity (Figure 1E). CD63 is a marker for extracellular vesicles in general, while CD81 is a specific marker for exosomes [49,50].
The proteomic analysis identified a total of 722 protein hits in all experimental groups. According to the maximum parsimony analysis, this study identified 330 proteins among the RPMI (negative control group), PMA (positive control group), and Cr-LAAO (experimental group). Detailed parameters for the identification of these proteins are provided in Supplementary Material S1.
Protein expression analyses revealed 206 common proteins among the three experimental groups. Specifically, 41 proteins were common between the control and Cr-LAAO groups, 81 proteins were exclusive to the control group compared to the Cr-LAAO group, and 28 proteins were exclusive to the Cr-LAAO group compared to the control group. Additionally, 9 proteins were common between the Cr-LAAO and PMA groups, 38 proteins were unique to the Cr-LAAO group compared to the PMA group, and 18 proteins were unique to the PMA group compared to the LAAO group. Finally, 30 proteins were common between the control and PMA groups, 89 proteins were unique to the control group compared to the PMA group, and 9 proteins were exclusive to the PMA group compared to the control group (Supplementary Materials S1 and S2).
The Volcano Plot indicated proteins that were differentially expressed in Cr-LAAO-stimulated neutrophils compared to the control group. These proteins exhibited a fold change of ≥2 and a T-test analysis p-value < 0.05 (Figure 2A). Spectral count data for proteins from both groups were subjected to PLS-DA analysis, and the plot scores demonstrated a clear separation of the two groups and their respective biological replicates. This separation indicated high reproducibility among the replicates and a significant differential effect in the presence of Cr-LAAO (Figure 2B). In Figure 2C, the results of the VIP score analysis are displayed, highlighting the most important proteins associated with Cr-LAAO’s impact on neutrophils. Proteins with a VIP score ≥ 1.7 were considered statistically significant. Table 1 presents the up-regulated and down-regulated proteins in Cr-LAAO-stimulated neutrophils obtained through Volcano Plot Analysis.
To gain a better understanding of the biological processes, molecular functions, and cellular components associated with the differentially expressed proteins in exosomes from Cr-LAAO-stimulated neutrophils, gene ontology analysis was conducted. Among the proteins corresponding to biological processes, 16 proteins (27% of them) were involved in cellular processes; 9 (15%) in metabolic processes; 7 (12%) in localization activities; 6 (10%) in response to stimuli; 5 (8%) in biological regulation; 4 (7%) in the regulation of biological processes; 4 (7%) in immune system processes; 3 (5%) in the organization of cellular components or biogenesis; 2 (3%) in the upregulation of biological processes; 2 (3%) in developmental processes; and 2 (3%) in multicellular organizational processes (Figure 3A).
Regarding the proteins involved in molecular functions (Figure 3B), it was found that 33 proteins (48%) were related to binding functions, 24 (35%) to catalytic activity, 7 (10%) to structural functions, and 5 (7%) to transport activation functions. In the cellular components category (Figure 3C), it was observed that 24 proteins (44%) were associated with cellular anatomical entities, 20 (36%) with intracellular regions, and 11 (20%) with components of protein complexes. Figure 4 is a graphical representation of information related to protein–protein interactions. These interactions involve proteins that were expressed differently in neutrophils after being treated with Cr-LAAO.

3. Discussion

In the present study, to identify the presence of exosomes in the extracellular medium, isolation was standardized by filtration through 0.45 and 0.22 µM nylon membranes, followed by ultracentrifugation. The precipitate was collected, and subsequently, a Western blot was performed using antibodies against surface protein markers (CD63 and CD81) present in these vesicles. Exosome isolation derived from stimulated neutrophils under different experimental conditions (control, PMA, and Cr-LAAO) was successfully obtained, consistent with the results published by Lasser et al. [48] and Majumdar et al. [26]. By stimulating neutrophils isolated from peripheral blood with fMLP, Majumdar et al. [26] observed bands corresponding to the intravesicular components of myeloperoxidase, metallopeptidase 9, and 5-lipoxygenase, as well as the surface markers found on exosomes.
Simultaneously, the size of the exosomes present in the extracellular medium was determined using dynamic light scattering (D.L.S) with a ZetaSizer, which measures particle size. In this study, particles ranging from 10 to 100 nm were obtained, demonstrating exosome heterogeneity. Yamashita et al. [51] identified a similar size and distribution pattern of exosomes in cell supernatant samples from murine melanoma after ultracentrifugation.
The Western blot assay confirmed that the vesicles were indeed exosomes, as they exhibited the characteristic tetraspanins, including CD63, on their cell surface. Tetraspanins contain four transmembrane domains and are responsible for forming networks with a wide variety of proteins, creating tetraspanin-enriched microdomains (TEMs) [52,53]. Tetraspanin molecules can associate with various adhesion molecules such as β1 integrin and receptors, performing functions like cell proliferation, adhesion, activation, and migration. CD63, the first tetraspanin characterized, was found to be present in all samples in this study.
Furthermore, CD61, known as β3 integrin, is also a cell surface protein belonging to the integrin family. Its relationship with exosomes is linked to the role played by β3 integrin in exosome biogenesis and release. Studies have shown that β3 integrin (CD61) is involved in forming integrin complexes on exosome membranes. These complexes may play a role in selecting and incorporating specific proteins into exosome vesicles during their formation. Additionally, the presence of CD61 on exosome membranes may influence their interaction with target cells through the recognition of specific ligands [54,55]. Data from the present study indicate that CD61 was expressed in exosomes from Cr-LAAO-stimulated neutrophils and the control groups, but there was no expression in the PMA-stimulated neutrophils group. The differences in cell activation induced by PMA and Cr-LAAO may occur through different mechanisms that trigger distinct cellular responses. These differences in activation mechanisms can be attributed to several factors, including variations in intracellular signaling pathways. These pathways have different targets and effects within the cell, resulting in diverse responses [56,57].
Regarding the protein–protein interactions among proteins differentially expressed in Cr-LAAO-stimulated neutrophils, several interesting associations were identified. Among these, proteins from the α and β tubulin family were observed. Deficiency in these proteins or dysfunction of microtubules can lead to various human conditions and disorders, including neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease [58], as well as breast cancer [59] and pancreatic cancer [60].
Two immune system proteins, myeloperoxidase (MPO) and complement 3 (C3), were also detected. These proteins play vital roles in the inflammatory response and the body’s defense against infections. Studies have suggested that MPO may influence complement activity [61,62]. MPO can modify C3, leading to its activation and the release of C3 fragments, which in turn can trigger inflammatory responses and attract immune cells to the site of infection [63,64].
Myosin and actin are the primary contractile proteins involved in muscle contraction. Myosin also plays a crucial structural role in maintaining the organization of these proteins in the sarcomere. Disruption in the function of these proteins can result in diseases such as cardiomyopathy and muscle paralysis [65,66,67]. It is important to note that these proteins have specific functions and interactions in various cellular contexts and physiological processes. There is no direct interaction between all of them in a single system or cellular event. Each of these proteins has its specific functions and roles in different biological systems and processes.
Additionally, the proteomic data from exosomes derived from Cr-LAAO-stimulated neutrophils, in comparison to the control, revealed the presence of several other proteins, including:
  • Desmin, encoded by the DES gene, represents a muscle-specific ɪɪɪ-type intermediate filament crucial for proper muscle structure and function [68];
  • Serpin B4, encoded by the SERPINB4 gene, can act as an inhibitor of parasitic and bacterial proteases, influence cell apoptosis, stimulate cell proliferation, and suppress immune defense against tumors [1,69,70];
  • Antithrombin ɪɪɪ, encoded by the SERPINC1 gene, is a major serine protease inhibitor in plasma that regulates the blood clotting cascade by neutralizing thrombin, thereby inhibiting thrombosis [71];
  • Titin, encoded by the TTN gene, is present in cardiac and skeletal muscles and functions as a “bidirectional spring” that regulates sarcomeric length and performs passive tension adjustments as needed [72,73,74];
  • Myomesin 1, encoded by the MYOM1 gene, acts as an elastic band to maintain the structural organization of the myofibrillar M band [75,76,77];
  • Voltage-dependent anion-selective channel protein 1, encoded by the VDAC1 gene, is found in eukaryotic cells and mediates the traffic of small molecules and ions across the outer mitochondrial membrane. It also interacts with anti-apoptotic proteins [78,79,80];
  • Carbonic anhydrase 3, encoded by the CA3 gene, plays an important role in the transport of carbon dioxide [81,82];
  • Kininogen-1, encoded by the KNG1 gene, is involved in blood clotting, inhibits thrombocyte aggregation, and has pro-inflammatory and pro-oxidant properties [83];
  • Immunoglobulin kappa constant is produced by B lymphocytes and is encoded by the IGKC gene [84,85];
  • Aconitate hydratase, encoded by the ACO2 gene, catalyzes the conversion of 2-oxoglutarate into succinyl-CoA and CO2 in the tricarboxylic acid cycle. It is mainly active in mitochondria [86,87];
  • Peptidase D, encoded by the PEPD gene, plays a role in proline recycling and may be a limiting factor for collagen production [88];
  • Sarcalumenin, encoded by the SRL gene, has a high capacity but low affinity for calcium binding [89,90];
  • Dihydrolipolysin succinyltransferase residue component of the 2-oxoglutarate dehydrogenase mitochondrial complex, encoded by the DLST gene, catalyzes the global conversion of 2-oxoglutarate into succinyl-CoA and CO2, primarily active in mitochondria [86,87].
Among the data, proteins related to exosome composition and involved in cell signaling were also detected, including the 14-3-3 proteins (zeta, epsilon, beta, eta, gamma, and theta), which are encoded by the genes YWHAZ, YWHAE, YWHAB, YWHAH, YWHAG, and YWHAQ, respectively. These regulatory proteins are primarily found in the cytosol and the extracellular environment. They have the capability to interact with over 200 signaling proteins, including kinases, phosphatases, transmembrane receptors, enzymes, structural and cytoskeletal proteins, proteins involved in transcriptional control, and proteins associated with apoptosis. Moreover, they have demonstrated effects on the inflammatory process and are involved in the regulation of cell proliferation, differentiation, and metabolism [91,92,93,94,95].
Peroxiredoxin-2, encoded by the PRDX2 gene, plays a role in cellular protection against oxidative stress by detoxifying peroxides. It also functions as a sensor of hydrogen peroxide-mediated signaling events and may participate in signaling cascades involving growth factors and tumor necrosis factor-alpha (TNF-α), regulating intracellular concentrations of H2O2 [96,97] which have a role in neutrophil activation induced by Cr-LAAO [17,18,19,20,21].
Histone H2B and H3.3 histone B, encoded by the genes H2BC15 and H3-3B in humans, are involved in the structure of eukaryotic cell chromatin. They play a role in the process of compacting and decompressing DNA, which is important for the formation of NETs [98,99] as observed in neutrophils stimulated by Cr-LAAO [17].
L-lactate dehydrogenase A chain and L-lactate dehydrogenase B chain, encoded by the LDHA, LDHB, and LDH genes, are primarily responsible for converting pyruvate into lactate and transforming NADH into NAD+. These proteins are related to the pyroptosis process [100,101,102,103,104].
Arginase 1, encoded by the ARG1 gene, is a key component of the urea cycle and induces a profound suppression of T cell proliferation and cytokine synthesis by neutrophils [105,106,107].
Table 2 displays the proteins identified in the proteomics data when comparing neutrophils stimulated by Cr-LAAO with those stimulated by PMA.
Proteins related to the composition of exosomes and involved in cell signaling were also detected, such as annexin A2, encoded by the ANXA2 gene in humans. This protein can bind to cell membranes in a calcium-dependent manner and is involved in a variety of cellular functions, including signaling processes, cytoskeletal regulation, and interactions with lipids [131,132].
Rab GDP dissociation beta inhibitor protein, encoded by the GDI2 gene in humans, plays a key role in the GTPase cycle of Rab proteins. It helps maintain Rab in its inactive GDP-bound state, contributing to the precise regulation of intracellular vesicular trafficking and membrane transport. This regulation is essential for normal cell function and for maintaining the structure and function of cell compartments [133,134].
Coronin-1A, encoded by the CORO1A gene in humans, plays a key role in regulating the actin cytoskeleton. It influences cell migration, phagocytosis, cell shape, and signaling pathways in different cell types, especially in cells of the immune system [135,136] which were observed in neutrophils stimulated by Cr-LAAO [17,18,19,20,21].
Talin-1, encoded by the TLN1 gene in humans, is a protein involved in the formation of focal adhesions, which are points of contact between the cell and the extracellular matrix. These adhesions allow the transmission of mechanical signals and regulate cell adhesion and migration [137,138,139].
In conclusion, the data from the present study revealed that Cr-LAAO activates human neutrophils in vitro, stimulating the production of extracellular vesicles called exosomes, which may play an important role in cell-to-cell communication and the regulation of inflammatory processes. Proteomic analysis revealed the presence of several proteins involved in fundamental cellular processes, such as the regulation of the immune response, muscle contraction, and blood clotting. These findings highlight the importance of investigating the role of exosomes and differentially expressed proteins in Cr-LAAO-activated neutrophils, both in the physiological and pathological context. Understanding these mechanisms can provide valuable insights for the development of new therapeutic strategies and biomarkers in inflammatory and immunological diseases.

4. Material and Methods

4.1. Chemicals and Reagents

Turk’s solution, RPMI-1640, L-glutamine, gentamicin, fetal bovine serum (FBS), and Histopaque 1077 were purchased from Sigma-Aldrich Chem. Co. (Saint Louis, MO, USA). Antibodies for CD63 and CD81 were purchased from Invitrogen (Carlsbad, CA, USA) Pierce™ Chromogenic Endotoxin Quant Kit was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Salts and reagents used in this study were obtained from Merck Millipore (Darmstadt, Germany) with low endotoxin or endotoxin-free grades, lysis buffer (NH4Cl 150 mM, KHCO3 10 mM, Na2-EDTA 0.1 mM, pH 7.2), and phosphate buffer saline (PBS: NaCl 137 mM, KCl 2.7 mM, Na2HPO4.2H2O 9.1 mM, KH2PO4 1.8 mM, pH 7.4).

4.2. Cr-LAAO Isolation

The Cr-LAAO isolation was performed following the protocol published by Pontes et al. [17] and Paloschi et al. [20]. The presence of endotoxin in Cr-LAAO samples was determined using the Quant kit derived from Pierce™ Chromogenic Endotoxin. The Cr-LAAO preparation exhibited the presence of 0.1 EU/mL of endotoxin, which was within the acceptable threshold of 1 EU/mL [21].

4.3. Isolation and Activation of Neutrophils

Neutrophils were isolated from peripheral blood obtained from healthy self-donors aged 18 to 40 years. Donors provided informed consent before blood collection, and all procedures were conducted per applicable regulations. The study was approved by the Ethical Committee of the Center of Tropical Medicine Research (CEPEM, Rondônia, Brazil—approval number CAAE 77529817.8.0000.0011), and participants provided informed consent before participating in the study according to the method described by Pontes et al. [17] and Paloschi et al. [21].

4.4. Exosomes Isolation

For exosome isolation, 1 × 107 human neutrophils were obtained from three donors (3 Ns) and were incubated for 3 h at 37 °C, in a humidified atmosphere with 5% CO2 with 100 µg/mL of Cr-LAAO (experimental group), 500 ng/mL of PMA (positive control) and RPMI without supplementation (negative control) in a final volume of 400 µL. After the end of the incubation, the samples were centrifuged at 400× g for 10 min at 4 °C to remove the cells. Protease and phosphatase inhibitors (1 μg/mL) were added to the supernatant and subjected to sequential filtration through 0.45 and 0.22 µm filters to retain cell debris and particles larger than 200 nm. Then, the samples were subjected to ultracentrifugation at 100,000× g for 3 h at 4 °C. The precipitate containing the exosomes was resuspended in 200 µL of PBS containing protease and phosphatase inhibitors (1 µg/mL). The homogeneity of exosome size was determined using Zetasizer Nano ZS90 (Malvern Instruments, Orsay, France). A total of 1 μL of each preparation (experimental group, negative and positive control groups) was diluted in 999 μL of PBS, and the parameters of size distribution and zeta potential (electronegativity) of the exosomes were analyzed at 37 °C according to Khashayar et al. [140].

4.5. Protein Profile of Neutrophil Supernatants

An aliquot of each homogeneity of the exosomes was taken to determine the protein concentration by the BCA colorimetric method (Bicinchoninic Acid Protein Assay Kit, Sigma-Aldrich, St. Louis, MO, USA). To evaluate the protein profile after ultracentrifugation, the samples (20 µg) were incubated with 0.02% bromophenol blue, 10 mM mercaptoethanol, and 10% sodium dodecyl sulfate (SDS) for 5 min at 95 °C for protein denaturation. Then, they were separated on a 12% (w/v) polyacrylamide gel (SDS-PAGE). In the electrophoretic run, a constant current of 90 volts was fixed and, between 10–15 °C, to avoid band distortions and, consequently, resolution problems. For comparison purposes, 5 μL of Molecular Weight Standard (10–230 kDa Biolabs) was added to each electrophoretic run. The gel was stained with Coomassie Blue, and the bands were visualized directly.

4.6. Western Blot Protein Expression

For protein expression analysis, the proteins were electrotransferred to the adsorbent 0.45 µm nitrocellulose membrane, previously hydrated in water for 2–3 min in a transfer buffer for 5 min. The membrane was blocked with 3% (v/v) bovine serum albumin (BSA) for 1 h. After three 5 min washing steps with TPBS (PBS and 0.1% Tween), the primary antibodies to CD63 and CD81 were diluted in the titration established by the manufacturer and dispensed on the membrane, followed by incubation for 18 h at 20 °C. The washing steps were repeated, and then a secondary antibody conjugated with peroxidase (Sigma-Aldrich) was added and incubated for 2 h. After the washing steps, the membrane was developed using diaminobenzidine (DAB), 1 M Tris HCl pH 6.8, and 30% H2O2 [19].

4.7. Proteomic Analysis

Protein bands of each sample from RPMI (negative group), PMA (positive control), and Cr-LAAO (experimental group) were excised and submitted to in-gel digestion protein according to Shevchenko et al. [141] using trypsin as a proteolytic enzyme. Then, peptides were extracted from the gel matrix, followed by desalting in homemade C18 stage tips. The peptides were analyzed by LC-MS/MS in triplicate in an EASY nLC 1000 coupled to an LTQ Orbitrap XL ETD mass spectrometer (Thermo Scientific) equipped with a nanoelectrospray ion source (Phoenix S&T) at the Mass Spectrometry Facility RPT02H at Instituto Carlos Chagas, FIOCRUZ (Curitiba, Parana, Brazil) according to Forrest et al. [142].

4.8. Mass Spectrometry Data Analysis

Raw mass spectrometry data in RAW format was submitted to PatternLab software [version 4.0.0.84] [143] to obtain protein identification. The main parameters used in this tool were the UNIPROT database (Taxonomy Homo sapiens; 74,788 proteins, 5 November 2019); trypsin enzyme; allowance for 2 stray cleavages; post-translational modification carbamidomethylation of cysteine residues; variable post-translational modification oxidation of methionine residues; and MS 40 ppm and MS/MS tolerance errors of 0.0200 ppm. The maximum FDR (False Discovery) rate was considered to be ≤1%. A matrix compatible with the MetaboAnalyst 4.0® program (https://www.metaboanalyst.ca/ accessed on 4 February 2022.) was constructed using the proteomic data. The spectral counts were normalized for each protein identified by the weighted average of the duplicate of each sample [144]. Proteins that have been identified in less than 70% of the samples were excluded from the analysis. Partial Least Squares (PLS) was used as the main method of multivariate analysis. Only signals present in 80% of the samples were considered for the generation of statistical models. Proteins were subjected to enrichment analysis for Gene Ontology (GO) terms “molecular function”, “biological process”, and “cellular component” using Panther software (www.pantherdb.org (accessed on 4 March 2023)). Protein interactions were also investigated regarding their biological processes using the STRING software, version 12.0 (http://string-db.org (accessed on 15 March 2023)), using the basic parameters: cut-off score of 0.90, confidence as network edges, and PPI enrichment p-value of <1.0 × 10−16.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxins15110625/s1, Supplementary Material S1: Detailed parameters for the identification of proteins. Supplementary Material S2: Table S1–S6, electrophoretic profile and western blot.

Author Contributions

J.P.Z. and A.S.P. designed the study; S.N.S., A.S.P., M.V.P., M.D.S.S., J.A.L., C.P.S., H.M.S., C.N.B., D.G.C., A.V.E.U., J.G.S.M. and L.F.C. performed the experiments; S.N.S., A.S.P., M.V.P., B.C.-M. and L.D.S. analyzed the data; A.M.S. provided the protein; J.P.Z., C.N.B. and S.S.S. provided reagents; J.P.Z., S.N.S., A.S.P. and M.V.P. wrote the manuscript. All authors discussed the results as well as their implications and commented on the manuscript at all stages. All authors have read and agreed to the published version of the manuscript.

Funding

The authors express their gratitude to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Fundação de Amparo à Pesquisa do Estado de Rondônia (FAPERO) for the financial support. This study was supported by grants (306197/2017-0 and 405120/2018-4) from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). The authors thank the Network Technological Platforms from FIOCRUZ (https://plataformas.fiocruz.br/ (accessed on 25 October 2021)) for the support and financing of the services provided by the Mass Spectrometry Facility RPT02H at Instituto Carlos Chagas, FIOCRUZ, Curitiba, Parana. Juliana Pavan Zuliani was a recipient of productivity grants 306197/2017-0, and 311696/2021-0 from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)—Finance Code 001. Suzanne Serrath was a beneficiary of the CAPES master fellowship and Adriana Silva Pontes was a recipient of PNPD/CAPES Pos-Doc (Programa Nacional de Pos Doutorado da CAPES).

Institutional Review Board Statement

The study was approved by the Ethical Committee of the Center of Tropical Medicine Research (CEPEM, Rondônia, Brazil—approval number CAAE 77529817.8.0000.0011).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to confidentiality reasons as they are stored in the Fiocruz Rondônia archives.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhang, Y.; Wang, L.; Sun, X.; Li, F. SERPINB4 Promotes Keratinocyte Inflammation via P38MAPK Signaling Pathway. J. Immunol. Res. 2023, 2023, 3397940. [Google Scholar] [CrossRef] [PubMed]
  2. Du, X.-Y.; Clemetson, K.J. Snake Venom L-Amino Acid Oxidases. Toxicon 2002, 40, 659–665. [Google Scholar] [CrossRef] [PubMed]
  3. Zuliani, J.; Kayano, A.; Zaqueo, K.; Neto, A.; Sampaio, S.; Soares, A.; Stabeli, R. Snake Venom L-Amino Acid Oxidases: Some Consideration About Their Functional Characterization. Protein Pept. Lett. 2009, 16, 908–912. [Google Scholar] [CrossRef] [PubMed]
  4. da Silva, S.L.; Calderon, L.A.; Zanchi, F.B.; Mendes, M.M.; Grabner, A.N.; Zuliani, J.P.; Fernandes, C.F.C.; Izidoro, L.F.M.; Costa, T.R.; Stábeli, R.G.; et al. Snake Venom L-Amino Acid Oxidases: Trends in Pharmacology and Biochemistry. Biomed. Res. Int. 2014, 2014, 196754. [Google Scholar] [CrossRef]
  5. Paloschi, M.V.; Pontes, A.S.; Soares, A.M.; Zuliani, J.P. An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-Amino Acid Oxidases (LAAOs). Curr. Med. Chem. 2018, 25, 2520–2530. [Google Scholar] [CrossRef]
  6. Guo, C.; Liu, S.; Yao, Y.; Zhang, Q.; Sun, M.-Z. Past Decade Study of Snake Venom L-Amino Acid Oxidase. Toxicon 2012, 60, 302–311. [Google Scholar] [CrossRef]
  7. Zuliani, J.P.; Paloschi, M.V.; Pontes, A.S.; Boeno, C.N.; Lopes, J.A.; Setubal, S.S.; Zanchi, F.B.; Soares, A.M. Reptile Venom L-Amino Acid Oxidases—Structure and Function. In Handbook of Venoms and Toxins of Reptiles; CRC Press: Boca Raton, FL, USA, 2021; Volume 2, pp. 413–430. [Google Scholar] [CrossRef]
  8. Suhr, S.M.; Kim, D.S. Identification of the Snake Venom Substance That Induces Apoptosis. Biochem. Biophys. Res. Commun. 1996, 224, 134–139. [Google Scholar] [CrossRef]
  9. Ahn, M.Y.; Lee, B.M.; Kim, Y.S. Characterization and Cytotoxicity of L-Amino Acid Oxidase from the Venom of King Cobra (Ophiophagus hannah). Int. J. Biochem. Cell Biol. 1997, 29, 911–919. [Google Scholar] [CrossRef]
  10. Li, Z.-Y.; Yu, T.-F.; Lian, E.C.-Y. Purification and Characterization of L-Amino Acid Oxidase from King Cobra (Ophiophagus hannah) Venom and Its Effects on Human Platelet Aggregation. Toxicon 1994, 32, 1349–1358. [Google Scholar] [CrossRef]
  11. Sakurai, Y.; Shima, M.; Matsumoto, T.; Takatsuka, H.; Nishiya, K.; Kasuda, S.; Fujimura, Y.; Yoshioka, A. Anticoagulant Activity of M-LAO, l-Amino Acid Oxidase Purified from Agkistrodon Halys Blomhoffii, through Selective Inhibition of Factor IX. Biochim. Biophys. Acta-Proteins Proteom. 2003, 1649, 51–57. [Google Scholar] [CrossRef]
  12. Abe, Y.; Shimoyama, Y.; Munakata, H.; Ito, J.; Nagata, N.; Ohtsuki, K. Characterization of an Apoptosis-Inducing Factor in Habu Snake Venom as a Glycyrrhizin (GL)-Binding Protein Potently Inhibited by GL in Vitro. Biol. Pharm. Bull. 1998, 21, 924–927. [Google Scholar] [CrossRef] [PubMed]
  13. Stábeli, R.G.; Marcussi, S.; Carlos, G.B.; Pietro, R.C.L.R.; Selistre-de-Araújo, H.S.; Giglio, J.R.; Oliveira, E.B.; Soares, A.M. Platelet Aggregation and Antibacterial Effects of an L-Amino Acid Oxidase Purified from Bothrops Alternatus Snake Venom. Bioorg. Med. Chem. 2004, 12, 2881–2886. [Google Scholar] [CrossRef] [PubMed]
  14. França, S.C.; Kashima, S.; Roberto, P.G.; Marins, M.; Ticli, F.K.; Pereira, J.O.; Astolfi-Filho, S.; Stábeli, R.G.; Magro, A.J.; Fontes, M.R.M.; et al. Molecular Approaches for Structural Characterization of Bothrops L-Amino Acid Oxidases with Antiprotozoal Activity: CDNA Cloning, Comparative Sequence Analysis, and Molecular Modeling. Biochem. Biophys. Res. Commun. 2007, 355, 302–306. [Google Scholar] [CrossRef] [PubMed]
  15. Tempone, A.G.; Andrade, H.F.; Spencer, P.J.; Lourenço, C.O.; Rogero, J.R.; Nascimento, N. Bothrops Moojeni Venom Kills Leishmania Spp. with Hydrogen Peroxide Generated by Its -Amino Acid Oxidase. Biochem. Biophys. Res. Commun. 2001, 280, 620–624. [Google Scholar] [CrossRef] [PubMed]
  16. Fung, S.Y.; Lee, M.L.; Tan, N.H. Molecular Mechanism of Cell Death Induced by King Cobra (Ophiophagus hannah) Venom l-Amino Acid Oxidase. Toxicon 2015, 96, 38–45. [Google Scholar] [CrossRef] [PubMed]
  17. Pontes, A.S.; da S. Setúbal, S.; Xavier, C.V.; Lacouth-Silva, F.; Kayano, A.M.; Pires, W.L.; Nery, N.M.; Boeri de Castro, O.; da Silva, S.D.; Calderon, L.A.; et al. Effect of L-Amino Acid Oxidase from Calloselasma Rhodosthoma Snake Venom on Human Neutrophils. Toxicon 2014, 80, 27–37. [Google Scholar] [CrossRef] [PubMed]
  18. Pontes, A.S.; Setúbal, S.D.S.; Nery, N.M.; Da Silva, F.S.; Da Silva, S.D.; Fernandes, C.F.C.; Stábeli, R.G.; Soares, A.M.; Zuliani, J.P. P38 MAPK Is Involved in Human Neutrophil Chemotaxis Induced by L-Amino Acid Oxidase from Calloselasma Rhodosthoma. Toxicon 2016, 119, 106–116. [Google Scholar] [CrossRef]
  19. Paloschi, M.V.; Boeno, C.N.; Lopes, J.A.; Eduardo dos Santos da Rosa, A.; Pires, W.L.; Pontes, A.S.; da Silva Setúbal, S.; Soares, A.M.; Zuliani, J.P. Role of L-Amino Acid Oxidase Isolated from Calloselasma Rhodostoma Venom on Neutrophil NADPH Oxidase Complex Activation. Toxicon 2018, 145, 48–55. [Google Scholar] [CrossRef]
  20. Paloschi, M.V.; Lopes, J.A.; Boeno, C.N.; Silva, M.D.S.; Evangelista, J.R.; Pontes, A.S.; da Silva Setúbal, S.; Rego, C.M.A.; Néry, N.M.; Ferreira e Ferreira, A.A.; et al. Cytosolic Phospholipase A2-α Participates in Lipid Body Formation and PGE2 Release in Human Neutrophils Stimulated with an l-Amino Acid Oxidase from Calloselasma Rhodostoma Venom. Sci. Rep. 2020, 10, 10976. [Google Scholar] [CrossRef]
  21. Paloschi, M.V.; Boeno, C.N.; Lopes, J.A.; Rego, C.M.A.; Silva, M.D.S.; Santana, H.M.; Serrath, S.N.; Ikenohuchi, Y.J.; Farias, B.J.C.; Felipin, K.P.; et al. Reactive Oxygen Species-Dependent-NLRP3 Inflammasome Activation in Human Neutrophils Induced by l-Amino Acid Oxidase Derived from Calloselasma Rhodostoma Venom. Life Sci. 2022, 308, 120962. [Google Scholar] [CrossRef]
  22. Torii, S.; Naito, M.; Tsuruo, T. Apoxin I, a Novel Apoptosis-Inducing Factor with L-Amino Acid Oxidase Activity Purified from Western Diamondback Rattlesnake Venom. J. Biol. Chem. 1997, 272, 9539–9542. [Google Scholar] [CrossRef] [PubMed]
  23. Suhr, S.-M.; Kim, D.-S. Comparison of the Apoptotic Pathways Induced by L-Amino Acid Oxidase and Hydrogen Peroxide. J. Biochem. 1999, 125, 305–309. [Google Scholar] [CrossRef] [PubMed]
  24. Costa, T.R.; Menaldo, D.L.; Zoccal, K.F.; Burin, S.M.; Aissa, A.F.; de Castro, F.A.; Faccioli, L.H.; Greggi Antunes, L.M.; Sampaio, S.V. CR-LAAO, an L-Amino Acid Oxidase from Calloselasma Rhodostoma Venom, as a Potential Tool for Developing Novel Immunotherapeutic Strategies against Cancer. Sci. Rep. 2017, 7, 42673. [Google Scholar] [CrossRef] [PubMed]
  25. van der Pol, E.; Böing, A.N.; Harrison, P.; Sturk, A.; Nieuwland, R. Classification, Functions, and Clinical Relevance of Extracellular Vesicles. Pharmacol. Rev. 2012, 64, 676–705. [Google Scholar] [CrossRef]
  26. Majumdar, R.; Tavakoli Tameh, A.; Arya, S.B.; Parent, C.A. Exosomes Mediate LTB4 Release during Neutrophil Chemotaxis. PLoS Biol. 2021, 19, e3001271. [Google Scholar] [CrossRef]
  27. Higginbotham, J.N.; Demory Beckler, M.; Gephart, J.D.; Franklin, J.L.; Bogatcheva, G.; Kremers, G.-J.; Piston, D.W.; Ayers, G.D.; McConnell, R.E.; Tyska, M.J.; et al. Amphiregulin Exosomes Increase Cancer Cell Invasion. Curr. Biol. 2011, 21, 779–786. [Google Scholar] [CrossRef]
  28. Atayde, V.D.; Hassani, K.; da Silva Lira Filho, A.; Borges, A.R.; Adhikari, A.; Martel, C.; Olivier, M. Leishmania Exosomes and Other Virulence Factors: Impact on Innate Immune Response and Macrophage Functions. Cell. Immunol. 2016, 309, 7–18. [Google Scholar] [CrossRef]
  29. Karasu, E.; Eisenhardt, S.U.; Harant, J.; Huber-Lang, M. Extracellular Vesicles: Packages Sent with Complement. Front. Immunol. 2018, 9, 721. [Google Scholar] [CrossRef]
  30. Han, Q.-F.; Li, W.-J.; Hu, K.-S.; Gao, J.; Zhai, W.-L.; Yang, J.-H.; Zhang, S.-J. Exosome Biogenesis: Machinery, Regulation, and Therapeutic Implications in Cancer. Mol. Cancer 2022, 21, 207. [Google Scholar] [CrossRef]
  31. Ludwig, A.-K.; Giebel, B. Exosomes: Small Vesicles Participating in Intercellular Communication. Int. J. Biochem. Cell Biol. 2012, 44, 11–15. [Google Scholar] [CrossRef]
  32. Yang, D.; Zhang, W.; Zhang, H.; Zhang, F.; Chen, L.; Ma, L.; Larcher, L.M.; Chen, S.; Liu, N.; Zhao, Q.; et al. Progress, Opportunity, and Perspective on Exosome Isolation—Efforts for Efficient Exosome-Based Theranostics. Theranostics 2020, 10, 3684–3707. [Google Scholar] [CrossRef] [PubMed]
  33. Akers, J.C.; Gonda, D.; Kim, R.; Carter, B.S.; Chen, C.C. Biogenesis of Extracellular Vesicles (EV): Exosomes, Microvesicles, Retrovirus-like Vesicles, and Apoptotic Bodies. J. Neurooncol. 2013, 113, 1–11. [Google Scholar] [CrossRef] [PubMed]
  34. Kalluri, R.; LeBleu, V.S. The Biology, Function, and Biomedical Applications of Exosomes. Science (80-) 2020, 367. [Google Scholar] [CrossRef] [PubMed]
  35. Ahsan, N.A.; Sampey, G.C.; Lepene, B.; Akpamagbo, Y.; Barclay, R.A.; Iordanskiy, S.; Hakami, R.M.; Kashanchi, F. Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection. Front. Microbiol. 2016, 7, 139. [Google Scholar] [CrossRef]
  36. Zhou, Z.; Chen, Y.; Qian, X. Target-Specific Exosome Isolation through Aptamer-Based Microfluidics. Biosensors 2022, 12, 257. [Google Scholar] [CrossRef]
  37. Lee, S.Y.; Lee, J.W. 3D Spheroid Cultures of Stem Cells and Exosome Applications for Cartilage Repair. Life 2022, 12, 939. [Google Scholar] [CrossRef]
  38. Ye, Q.; Li, Z.; Li, Y.; Li, Y.; Zhang, Y.; Gui, R.; Cui, Y.; Zhang, Q.; Qian, L.; Xiong, Y.; et al. Exosome-Derived MicroRNA: Implications in Melanoma Progression, Diagnosis and Treatment. Cancers 2022, 15, 80. [Google Scholar] [CrossRef]
  39. Aswad, H.; Forterre, A.; Wiklander, O.P.B.; Vial, G.; Danty-Berger, E.; Jalabert, A.; Lamazière, A.; Meugnier, E.; Pesenti, S.; Ott, C.; et al. Exosomes Participate in the Alteration of Muscle Homeostasis during Lipid-Induced Insulin Resistance in Mice. Diabetologia 2014, 57, 2155–2164. [Google Scholar] [CrossRef]
  40. Ratajczak, J.; Miekus, K.; Kucia, M.; Zhang, J.; Reca, R.; Dvorak, P.; Ratajczak, M.Z. Embryonic Stem Cell-Derived Microvesicles Reprogram Hematopoietic Progenitors: Evidence for Horizontal Transfer of MRNA and Protein Delivery. Leukemia 2006, 20, 847–856. [Google Scholar] [CrossRef]
  41. Distler, J.H.W.; Huber, L.C.; Gay, S.; Distler, O.; Pisetsky, D.S. Microparticles as Mediators of Cellular Cross-Talk in Inflammatory Disease. Autoimmunity 2006, 39, 683–690. [Google Scholar] [CrossRef]
  42. Boulanger, C.M.; Amabile, N.; Tedgui, A. Circulating Microparticles. Hypertension 2006, 48, 180–186. [Google Scholar] [CrossRef]
  43. Bobrie, A.; Colombo, M.; Raposo, G.; Théry, C. Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses. Traffic 2011, 12, 1659–1668. [Google Scholar] [CrossRef] [PubMed]
  44. Li, S.; Li, S.; Wu, S.; Chen, L. Exosomes Modulate the Viral Replication and Host Immune Responses in HBV Infection. Biomed. Res. Int. 2019, 2019, 2103943. [Google Scholar] [CrossRef] [PubMed]
  45. Ratajczak, M.Z.; Ratajczak, J. Innate Immunity Communicates Using the Language of Extracellular Microvesicles. Stem Cell Rev. Rep. 2021, 17, 502–510. [Google Scholar] [CrossRef] [PubMed]
  46. Zhang, T.; Zhao, L.; Han, L.; Li, Y.; Hu, L.; Wang, H.; Zou, F. TRX2/Rab35 Interaction Impairs Exosome Secretion by Inducing Rab35 Degradation. Int. J. Mol. Sci. 2022, 23, 6557. [Google Scholar] [CrossRef]
  47. Heo, J.; Kang, H. Exosome-Based Treatment for Atherosclerosis. Int. J. Mol. Sci. 2022, 23, 1002. [Google Scholar] [CrossRef]
  48. Lässer, C.; Eldh, M.; Lötvall, J. Isolation and Characterization of RNA-Containing Exosomes. J. Vis. Exp. 2012. [Google Scholar] [CrossRef]
  49. Khashayar, P.; Amoabediny, G.; Larijani, B.; Hosseini, M.; Vanfleteren, J. Fabrication and Verification of Conjugated AuNP-Antibody Nanoprobe for Sensitivity Improvement in Electrochemical Biosensors. Sci. Rep. 2017, 7, 16070. [Google Scholar] [CrossRef]
  50. Shevchenko, A.; Tomas, H.; Havli, J.; Olsen, J.V.; Mann, M. In-Gel Digestion for Mass Spectrometric Characterization of Proteins and Proteomes. Nat. Protoc. 2006, 1, 2856–2860. [Google Scholar] [CrossRef]
  51. Forrest, D.M.; Batista, M.; Marchini, F.K.; Tempone, A.J.; Traub-Csekö, Y.M. Proteomic Analysis of Exosomes Derived from Procyclic and Metacyclic-like Cultured Leishmania Infantum Chagasi. J. Proteom. 2020, 227, 103902. [Google Scholar] [CrossRef]
  52. Carvalho, P.C.; Lima, D.B.; Leprevost, F.V.; Santos, M.D.M.; Fischer, J.S.G.; Aquino, P.F.; Moresco, J.J.; Yates, J.R.; Barbosa, V.C. Integrated Analysis of Shotgun Proteomic Data with PatternLab for Proteomics 4.0. Nat. Protoc. 2016, 11, 102–117. [Google Scholar] [CrossRef] [PubMed]
  53. Chong, J.J.H.; Yang, X.; Don, C.W.; Minami, E.; Liu, Y.-W.; Weyers, J.J.; Mahoney, W.M.; Van Biber, B.; Cook, S.M.; Palpant, N.J.; et al. Human Embryonic-Stem-Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts. Nature 2014, 510, 273–277. [Google Scholar] [CrossRef] [PubMed]
  54. Colombo, M.; Raposo, G.; Théry, C. Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu. Rev. Cell Dev. Biol. 2014, 30, 255–289. [Google Scholar] [CrossRef]
  55. Eitan, E.; Suire, C.; Zhang, S.; Mattson, M.P. Impact of Lysosome Status on Extracellular Vesicle Content and Release. Ageing Res. Rev. 2016, 32, 65–74. [Google Scholar] [CrossRef]
  56. Yamashita, T.; Takahashi, Y.; Nishikawa, M.; Takakura, Y. Effect of Exosome Isolation Methods on Physicochemical Properties of Exosomes and Clearance of Exosomes from the Blood Circulation. Eur. J. Pharm. Biopharm. 2016, 98, 1–8. [Google Scholar] [CrossRef] [PubMed]
  57. Pols, M.S.; Klumperman, J. Trafficking and Function of the Tetraspanin CD63. Exp. Cell Res. 2009, 315, 1584–1592. [Google Scholar] [CrossRef]
  58. Kowal, E.J.K.; Ter-Ovanesyan, D.; Regev, A.; Church, G.M. Extracellular Vesicle Isolation and Analysis by Western Blotting. In Extracellular Vesicles. Methods in Molecular Biology; Humana Press: New York, NY, USA, 2017; pp. 143–152. [Google Scholar]
  59. Multia, E.; Tear, C.J.Y.; Palviainen, M.; Siljander, P.; Riekkola, M.-L. Fast Isolation of Highly Specific Population of Platelet-Derived Extracellular Vesicles from Blood Plasma by Affinity Monolithic Column, Immobilized with Anti-Human CD61 Antibody. Anal. Chim. Acta 2019, 1091, 160–168. [Google Scholar] [CrossRef]
  60. Palviainen, M.; Saraswat, M.; Varga, Z.; Kitka, D.; Neuvonen, M.; Puhka, M.; Joenväärä, S.; Renkonen, R.; Nieuwland, R.; Takatalo, M.; et al. Extracellular Vesicles from Human Plasma and Serum Are Carriers of Extravesicular Cargo—Implications for Biomarker Discovery. PLoS ONE 2020, 15, e0236439. [Google Scholar] [CrossRef]
  61. Goel, G.; Makkar, H.P.S.; Francis, G.; Becker, K. Phorbol Esters: Structure, Biological Activity, and Toxicity in Animals. Int. J. Toxicol. 2007, 26, 279–288. [Google Scholar] [CrossRef]
  62. Antebi, Y.E.; Nandagopal, N.; Elowitz, M.B. An Operational View of Intercellular Signaling Pathways. Curr. Opin. Syst. Biol. 2017, 1, 16–24. [Google Scholar] [CrossRef]
  63. Carmona, B.; Marinho, H.S.; Matos, C.L.; Nolasco, S.; Soares, H. Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation. Biology 2023, 12, 561. [Google Scholar] [CrossRef]
  64. Boggs, A.E.; Vitolo, M.I.; Whipple, R.A.; Charpentier, M.S.; Goloubeva, O.G.; Ioffe, O.B.; Tuttle, K.C.; Slovic, J.; Lu, Y.; Mills, G.B.; et al. α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration. Cancer Res. 2015, 75, 203–215. [Google Scholar] [CrossRef]
  65. Seeley, E.S.; Carrière, C.; Goetze, T.; Longnecker, D.S.; Korc, M. Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia. Cancer Res. 2009, 69, 422–430. [Google Scholar] [CrossRef]
  66. Segelmark, M.; Persson, B.; Hellmark, T.; Wieslander, J. Binding and Inhibition of Myeloperoxidase (MPO): A Major Function of Ceruloplasmin? Clin. Exp. Immunol. 2003, 108, 167–174. [Google Scholar] [CrossRef]
  67. Hilhorst, M.; van Paassen, P.; van Rie, H.; Bijnens, N.; Heerings-Rewinkel, P.; van Breda Vriesman, P.; Cohen Tervaert, J.W. Complement in ANCA-Associated Glomerulonephritis. Nephrol. Dial. Transplant. 2017, 32, 1302–1313. [Google Scholar] [CrossRef]
  68. Hakroush, S.; Tampe, D.; Korsten, P.; Ströbel, P.; Tampe, B. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis. Int. J. Mol. Sci. 2021, 22, 6588. [Google Scholar] [CrossRef]
  69. Baier, E.; Tampe, D.; Kluge, I.A.; Hakroush, S.; Tampe, B. Implication of Platelets and Complement C3 as Link between Innate Immunity and Tubulointerstitial Injury in Renal Vasculitis with MPO-ANCA Seropositivity. Front. Immunol. 2022, 13, 1054457. [Google Scholar] [CrossRef]
  70. Siegert, R.; Perrot, A.; Keller, S.; Behlke, J.; Michalewska-Włudarczyk, A.; Wycisk, A.; Tendera, M.; Morano, I.; Özcelik, C. A Myomesin Mutation Associated with Hypertrophic Cardiomyopathy Deteriorates Dimerisation Properties. Biochem. Biophys. Res. Commun. 2011, 405, 473–479. [Google Scholar] [CrossRef]
  71. Prill, K.; Carlisle, C.; Stannard, M.; Windsor Reid, P.J.; Pilgrim, D.B. Myomesin Is Part of an Integrity Pathway That Responds to Sarcomere Damage and Disease. PLoS ONE 2019, 14, e0224206. [Google Scholar] [CrossRef]
  72. Lamber, E.P.; Guicheney, P.; Pinotsis, N. The Role of the M-Band Myomesin Proteins in Muscle Integrity and Cardiac Disease. J. Biomed. Sci. 2022, 29, 18. [Google Scholar] [CrossRef]
  73. Hnia, K.; Ramspacher, C.; Vermot, J.; Laporte, J. Desmin in Muscle and Associated Diseases: Beyond the Structural Function. Cell Tissue Res. 2015, 360, 591–608. [Google Scholar] [CrossRef]
  74. Watanabe, Y.; Yamaguchi, Y.; Komitsu, N.; Ohta, S.; Azuma, Y.; Izuhara, K.; Aihara, M. Elevation of Serum Squamous Cell Carcinoma Antigen 2 in Patients with Psoriasis: Associations with Disease Severity and Response to the Treatment. Br. J. Dermatol. 2016, 174, 1327–1336. [Google Scholar] [CrossRef]
  75. Ghonemy, S.; Mohamed, B.; Elkashishy, K.; Ibrahim, A.-S.M. Squamous Cell Carcinoma Antigen in Psoriasis: An Immunohistochemical Study. J. Clin. Aesthet. Dermatol. 2021, 14, 50–53. [Google Scholar]
  76. Szabo, R.; Netzel-Arnett, S.; Hobson, J.P.; Antalis, T.M.; Bugge, T.H. Matriptase-3 Is a Novel Phylogenetically Preserved Membrane-Anchored Serine Protease with Broad Serpin Reactivity. Biochem. J. 2005, 390, 231–242. [Google Scholar] [CrossRef]
  77. Castro-Ferreira, R.; Fontes-Carvalho, R.; Falcão-Pires, I.; Leite-Moreira, A.F. Papel Da Titina Na Modulação Da Função Cardíaca e Suas Implicações Fisiopatológicas. Arq. Bras. Cardiol. 2011, 96, 332–339. [Google Scholar] [CrossRef]
  78. Kellermayer, D.; Smith, J.E.; Granzier, H. Titin Mutations and Muscle Disease. Pflügers Arch.-Eur. J. Physiol. 2019, 471, 673–682. [Google Scholar] [CrossRef]
  79. Loescher, C.M.; Hobbach, A.J.; Linke, W.A. Titin (TTN): From Molecule to Modifications, Mechanics, and Medical Significance. Cardiovasc. Res. 2022, 118, 2903–2918. [Google Scholar] [CrossRef]
  80. Pinotsis, N.; Chatziefthimiou, S.D.; Berkemeier, F.; Beuron, F.; Mavridis, I.M.; Konarev, P.V.; Svergun, D.I.; Morris, E.; Rief, M.; Wilmanns, M. Superhelical Architecture of the Myosin Filament-Linking Protein Myomesin with Unusual Elastic Properties. PLoS Biol. 2012, 10, e1001261. [Google Scholar] [CrossRef]
  81. Pernigo, S.; Fukuzawa, A.; Beedle, A.E.M.; Holt, M.; Round, A.; Pandini, A.; Garcia-Manyes, S.; Gautel, M.; Steiner, R.A. Binding of Myomesin to Obscurin-Like-1 at the Muscle M-Band Provides a Strategy for Isoform-Specific Mechanical Protection. Structure 2017, 25, 107–120. [Google Scholar] [CrossRef]
  82. Hang, C.; Song, Y.; Li, Y.; Zhang, S.; Chang, Y.; Bai, R.; Saleem, A.; Jiang, M.; Lu, W.; Lan, F.; et al. Knockout of MYOM1 in Human Cardiomyocytes Leads to Myocardial Atrophy via Impairing Calcium Homeostasis. J. Cell. Mol. Med. 2021, 25, 1661–1676. [Google Scholar] [CrossRef]
  83. Blachly-Dyson, E.; Zambronicz, E.B.; Yu, W.H.; Adams, V.; McCabe, E.R.; Adelman, J.; Colombini, M.; Forte, M. Cloning and Functional Expression in Yeast of Two Human Isoforms of the Outer Mitochondrial Membrane Channel, the Voltage-Dependent Anion Channel. J. Biol. Chem. 1993, 268, 1835–1841. [Google Scholar] [CrossRef] [PubMed]
  84. Hiller, S.; Garces, R.G.; Malia, T.J.; Orekhov, V.Y.; Colombini, M.; Wagner, G. Solution Structure of the Integral Human Membrane Protein VDAC-1 in Detergent Micelles. Science (80-) 2008, 321, 1206–1210. [Google Scholar] [CrossRef] [PubMed]
  85. Dadsena, S.; Bockelmann, S.; Mina, J.G.M.; Hassan, D.G.; Korneev, S.; Razzera, G.; Jahn, H.; Niekamp, P.; Müller, D.; Schneider, M.; et al. Ceramides Bind VDAC2 to Trigger Mitochondrial Apoptosis. Nat. Commun. 2019, 10, 1832. [Google Scholar] [CrossRef] [PubMed]
  86. Wade, R.; Gunning, P.; Eddy, R.; Shows, T.; Kedes, L. Nucleotide Sequence, Tissue-Specific Expression, and Chromosome Location of Human Carbonic Anhydrase III: The Human CAIII Gene Is Located on the Same Chromosome as the Closely Linked CAI and CAII Genes. Proc. Natl. Acad. Sci. USA 1986, 83, 9571–9575. [Google Scholar] [CrossRef]
  87. Elder, I.; Fisher, Z.; Laipis, P.J.; Tu, C.; McKenna, R.; Silverman, D.N. Structural and Kinetic Analysis of Proton Shuttle Residues in the Active Site of Human Carbonic Anhydrase III. Proteins Struct. Funct. Bioinform. 2007, 68, 337–343. [Google Scholar] [CrossRef]
  88. Cheng, X.; Liu, D.; Song, H.; Tian, X.; Yan, C.; Han, Y. Overexpression of Kininogen-1 Aggravates Oxidative Stress and Mitochondrial Dysfunction in DOX-Induced Cardiotoxicity. Biochem. Biophys. Res. Commun. 2021, 550, 142–150. [Google Scholar] [CrossRef]
  89. Schroeder, H.W.; Cavacini, L. Structure and Function of Immunoglobulins. J. Allergy Clin. Immunol. 2010, 125, S41–S52. [Google Scholar] [CrossRef]
  90. McHeyzer-Williams, M.; Okitsu, S.; Wang, N.; McHeyzer-Williams, L. Molecular Programming of B Cell Memory. Nat. Rev. Immunol. 2012, 12, 24–34. [Google Scholar] [CrossRef]
  91. Wang, Y.; Guo, Y.R.; Liu, K.; Yin, Z.; Liu, R.; Xia, Y.; Tan, L.; Yang, P.; Lee, J.-H.; Li, X.; et al. KAT2A Coupled with the α-KGDH Complex Acts as a Histone H3 Succinyltransferase. Nature 2017, 552, 273–277. [Google Scholar] [CrossRef]
  92. Remacha, L.; Pirman, D.; Mahoney, C.E.; Coloma, J.; Calsina, B.; Currás-Freixes, M.; Letón, R.; Torres-Pérez, R.; Richter, S.; Pita, G.; et al. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas. Am. J. Hum. Genet. 2019, 104, 651–664. [Google Scholar] [CrossRef]
  93. Baszanowska, W.; Misiura, M.; Oscilowska, I.; Palka, J.; Miltyk, W. Extracellular Prolidase (PEPD) Induces Anabolic Processes through EGFR, Β1-Integrin, and IGF-1R Signaling Pathways in an Experimental Model of Wounded Fibroblasts. Int. J. Mol. Sci. 2021, 22, 942. [Google Scholar] [CrossRef]
  94. Jiao, Q.; Bai, Y.; Akaike, T.; Takeshima, H.; Ishikawa, Y.; Minamisawa, S. Sarcalumenin Is Essential for Maintaining Cardiac Function during Endurance Exercise Training. Am. J. Physiol. Circ. Physiol. 2009, 297, H576–H582. [Google Scholar] [CrossRef] [PubMed]
  95. Conte, E.; Dinoi, G.; Imbrici, P.; De Luca, A.; Liantonio, A. Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease. Cells 2023, 12, 715. [Google Scholar] [CrossRef]
  96. Fu, H.; Subramanian, R.R.; Masters, S.C. 14-3-3 Proteins: Structure, Function, and Regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 617–647. [Google Scholar] [CrossRef] [PubMed]
  97. Mhawech, P. 14-3-3 Proteins—An Update. Cell Res. 2005, 15, 228–236. [Google Scholar] [CrossRef] [PubMed]
  98. Kleppe, R.; Martinez, A.; Døskeland, S.O.; Haavik, J. The 14-3-3 Proteins in Regulation of Cellular Metabolism. Semin. Cell Dev. Biol. 2011, 22, 713–719. [Google Scholar] [CrossRef]
  99. Kaplan, A.; Bueno, M.; Fournier, A.E. Extracellular Functions of 14-3-3 Adaptor Proteins. Cell. Signal. 2017, 31, 26–30. [Google Scholar] [CrossRef]
  100. Munier, C.C.; Ottmann, C.; Perry, M.W.D. 14-3-3 Modulation of the Inflammatory Response. Pharmacol. Res. 2021, 163, 105236. [Google Scholar] [CrossRef]
  101. Low, F.M.; Hampton, M.B.; Winterbourn, C.C. Peroxiredoxin 2 and Peroxide Metabolism in the Erythrocyte. Antioxid. Redox Signal. 2008, 10, 1621–1630. [Google Scholar] [CrossRef]
  102. Liu, J.; Su, G.; Gao, J.; Tian, Y.; Liu, X.; Zhang, Z. Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of Its Molecular Mechanisms. Neurochem. Res. 2020, 45, 720–730. [Google Scholar] [CrossRef]
  103. Talbert, P.B.; Henikoff, S. Histone Variants at a Glance. J. Cell Sci. 2021, 134, jcs244749. [Google Scholar] [CrossRef]
  104. Buttress, T.; He, S.; Wang, L.; Zhou, S.; Saalbach, G.; Vickers, M.; Li, G.; Li, P.; Feng, X. Histone H2B.8 Compacts Flowering Plant Sperm through Chromatin Phase Separation. Nature 2022, 611, 614–622. [Google Scholar] [CrossRef] [PubMed]
  105. Read, J.A.; Winter, V.J.; Eszes, C.M.; Sessions, R.B.; Brady, R.L. Structural Basis for Altered Activity of M- and H-Isozyme Forms of Human Lactate Dehydrogenase. Proteins 2001, 43, 175–185. [Google Scholar] [CrossRef] [PubMed]
  106. Chen, Y.-J.; Mahieu, N.G.; Huang, X.; Singh, M.; Crawford, P.A.; Johnson, S.L.; Gross, R.W.; Schaefer, J.; Patti, G.J. Lactate Metabolism Is Associated with Mammalian Mitochondria. Nat. Chem. Biol. 2016, 12, 937–943. [Google Scholar] [CrossRef] [PubMed]
  107. Feng, Y.; Xiong, Y.; Qiao, T.; Li, X.; Jia, L.; Han, Y. Lactate Dehydrogenase A: A Key Player in Carcinogenesis and Potential Target in Cancer Therapy. Cancer Med. 2018, 7, 6124–6136. [Google Scholar] [CrossRef]
  108. Urbańska, K.; Orzechowski, A. Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells. Int. J. Mol. Sci. 2019, 20, 2085. [Google Scholar] [CrossRef]
  109. Park, J.S.; Saeed, K.; Jo, M.H.; Kim, M.W.; Lee, H.J.; Park, C.-B.; Lee, G.; Kim, M.O. LDHB Deficiency Promotes Mitochondrial Dysfunction Mediated Oxidative Stress and Neurodegeneration in Adult Mouse Brain. Antioxidants 2022, 11, 261. [Google Scholar] [CrossRef]
  110. Munder, M. Suppression of T-Cell Functions by Human Granulocyte Arginase. Blood 2006, 108, 1627–1634. [Google Scholar] [CrossRef]
  111. Niu, F.; Yu, Y.; Li, Z.; Ren, Y.; Li, Z.; Ye, Q.; Liu, P.; Ji, C.; Qian, L.; Xiong, Y. Arginase: An Emerging and Promising Therapeutic Target for Cancer Treatment. Biomed. Pharmacother. 2022, 149, 112840. [Google Scholar] [CrossRef]
  112. Zhang, H.; Zhu, X.; Friesen, T.J.; Kwak, J.W.; Pisarenko, T.; Mekvanich, S.; Velasco, M.A.; Randolph, T.W.; Kargl, J.; Houghton, A.M. Annexin A2/TLR2/MYD88 Pathway Induces Arginase 1 Expression in Tumor-Associated Neutrophils. J. Clin. Investig. 2022, 132, e153643. [Google Scholar] [CrossRef]
  113. Stanton, R.C. Glucose-6-Phosphate Dehydrogenase, NADPH, and Cell Survival. IUBMB Life 2012, 64, 362–369. [Google Scholar] [CrossRef] [PubMed]
  114. Chen, L.; Zhang, Z.; Hoshino, A.; Zheng, H.D.; Morley, M.; Arany, Z.; Rabinowitz, J.D. NADPH Production by the Oxidative Pentose-Phosphate Pathway Supports Folate Metabolism. Nat. Metab. 2019, 1, 404–415. [Google Scholar] [CrossRef] [PubMed]
  115. Cano, M.; Datta, S.; Wang, L.; Liu, T.; Flores-Bellver, M.; Sachdeva, M.; Sinha, D.; Handa, J.T. Nrf2 Deficiency Decreases NADPH from Impaired IDH Shuttle and Pentose Phosphate Pathway in Retinal Pigmented Epithelial Cells to Magnify Oxidative Stress-induced Mitochondrial Dysfunction. Aging Cell 2021, 20, e13444. [Google Scholar] [CrossRef] [PubMed]
  116. Tian, N.; Hu, L.; Lu, Y.; Tong, L.; Feng, M.; Liu, Q.; Li, Y.; Zhu, Y.; Wu, L.; Ji, Y.; et al. TKT Maintains Intestinal ATP Production and Inhibits Apoptosis-Induced Colitis. Cell Death Dis. 2021, 12, 853. [Google Scholar] [CrossRef] [PubMed]
  117. Baptista, I.; Karakitsou, E.; Cazier, J.-B.; Günther, U.L.; Marin, S.; Cascante, M. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-Phosphate Dehydrogenase and Glyceraldehyde-3-Phosphate Dehydrogenase Overexpression. Int. J. Mol. Sci. 2022, 23, 3574. [Google Scholar] [CrossRef] [PubMed]
  118. Hammers, C.M.; Stanley, J.R. Desmoglein-1, Differentiation, and Disease. J. Clin. Investig. 2013, 123, 1419–1422. [Google Scholar] [CrossRef] [PubMed]
  119. Kasperkiewicz, M.; Ellebrecht, C.T.; Takahashi, H.; Yamagami, J.; Zillikens, D.; Payne, A.S.; Amagai, M. Pemphigus. Nat. Rev. Dis. Prim. 2017, 3, 17026. [Google Scholar] [CrossRef] [PubMed]
  120. Hegazy, M.; Koetsier, J.L.; Huffine, A.L.; Broussard, J.A.; Godsel, B.M.; Cohen-Barak, E.; Sprecher, E.; Wolfgeher, D.J.; Kron, S.J.; Godsel, L.M.; et al. Epidermal Stratification Requires Retromer-Mediated Desmoglein-1 Recycling. Dev. Cell 2022, 57, 2683–2698. [Google Scholar] [CrossRef]
  121. Flix, B.; de la Torre, C.; Castillo, J.; Casal, C.; Illa, I.; Gallardo, E. Dysferlin Interacts with Calsequestrin-1, Myomesin-2 and Dynein in Human Skeletal Muscle. Int. J. Biochem. Cell Biol. 2013, 45, 1927–1938. [Google Scholar] [CrossRef]
  122. Sun, D.; Wu, R.; Zheng, J.; Li, P.; Yu, L. Polyubiquitin Chain-Induced P62 Phase Separation Drives Autophagic Cargo Segregation. Cell Res. 2018, 28, 405–415. [Google Scholar] [CrossRef]
  123. Han, S.-W.; Jung, B.-K.; Ryu, K.-Y. Regulation of Polyubiquitin Genes to Meet Cellular Ubiquitin Requirement. BMB Rep. 2021, 54, 189–195. [Google Scholar] [CrossRef]
  124. Dósa, A.; Csizmadia, T. The Role of K63-Linked Polyubiquitin in Several Types of Autophagy. Biol. Futur. 2022, 73, 137–148. [Google Scholar] [CrossRef] [PubMed]
  125. Niehaus, J.Z.; Good, M.; Jackson, L.E.; Ozolek, J.A.; Silverman, G.A.; Luke, C.J. Human SERPINB12 Is an Abundant Intracellular Serpin Expressed in Most Surface and Glandular Epithelia. J. Histochem. Cytochem. 2015, 63, 854–865. [Google Scholar] [CrossRef] [PubMed]
  126. Rosa, J.-P.; Raslova, H.; Bryckaert, M. Filamin A: Key Actor in Platelet Biology. Blood 2019, 134, 1279–1288. [Google Scholar] [CrossRef] [PubMed]
  127. Verdonschot, J.A.J.; Vanhoutte, E.K.; Claes, G.R.F.; Helderman-van den Enden, A.T.J.M.; Hoeijmakers, J.G.J.; Hellebrekers, D.M.E.I.; Haan, A.; Christiaans, I.; Lekanne Deprez, R.H.; Boen, H.M.; et al. A Mutation Update for the FLNC Gene in Myopathies and Cardiomyopathies. Hum. Mutat. 2020, 41, 1091–1111. [Google Scholar] [CrossRef]
  128. Yuen, M.; Ottenheijm, C.A.C. Nebulin: Big Protein with Big Responsibilities. J. Muscle Res. Cell Motil. 2020, 41, 103–124. [Google Scholar] [CrossRef]
  129. Wang, Z.; Grange, M.; Pospich, S.; Wagner, T.; Kho, A.L.; Gautel, M.; Raunser, S. Structures from Intact Myofibrils Reveal Mechanism of Thin Filament Regulation through Nebulin. Science (80-) 2022, 375. [Google Scholar] [CrossRef]
  130. Oi, N.; Yamamoto, H.; Langfald, A.; Bai, R.; Lee, M.-H.; Bode, A.M.; Dong, Z. LTA4H Regulates Cell Cycle and Skin Carcinogenesis. Carcinogenesis 2017, 38, 728–737. [Google Scholar] [CrossRef]
  131. Nordio, L.; Bazzocchi, C.; Genova, F.; Serra, V.; Longeri, M.; Franzo, G.; Rondena, M.; Stefanello, D.; Giudice, C. Molecular and Immunohistochemical Expression of LTA4H and FXR1 in Canine Oral Melanoma. Front. Vet. Sci. 2021, 8, 767887. [Google Scholar] [CrossRef]
  132. Lisowska-Myjak, B.; Jóźwiak-Kisielewska, A.; Łukaszkiewicz, J.; Skarżyńska, E. Vitamin D-Binding Protein as a Biomarker to Confirm Specific Clinical Diagnoses. Expert Rev. Mol. Diagn. 2020, 20, 49–56. [Google Scholar] [CrossRef]
  133. Wang, J.; Li, R.; Li, M.; Wang, C. Fibronectin and Colorectal Cancer: Signaling Pathways and Clinical Implications. J. Recept. Signal Transduct. 2021, 41, 313–320. [Google Scholar] [CrossRef] [PubMed]
  134. Zhang, Q.; Ul Ain, Q.; Schulz, C.; Pircher, J. Role of Antimicrobial Peptide Cathelicidin in Thrombosis and Thromboinflammation. Front. Immunol. 2023, 14, 1151926. [Google Scholar] [CrossRef] [PubMed]
  135. Patten, J.; Wang, K. Fibronectin in Development and Wound Healing. Adv. Drug Deliv. Rev. 2021, 170, 353–368. [Google Scholar] [CrossRef]
  136. Dallacasagrande, V.; Hajjar, K.A. Annexin A2 in Inflammation and Host Defense. Cells 2020, 9, 1499. [Google Scholar] [CrossRef]
  137. Lim, H.I.; Hajjar, K.A. Annexin A2 in Fibrinolysis, Inflammation and Fibrosis. Int. J. Mol. Sci. 2021, 22, 6836. [Google Scholar] [CrossRef] [PubMed]
  138. Zhang, W.; Liu, Z.; Xia, S.; Yao, L.; Li, L.; Gan, Z.; Tang, H.; Guo, Q.; Yan, X.; Sun, Z. GDI2 Is a Novel Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Aging 2021, 13, 25304–25324. [Google Scholar] [CrossRef]
  139. Wu, Y.; Yang, D.; Chen, G.-Y. Targeted Disruption of Gdi2 Causes Early Embryonic Lethality. Placenta 2022, 126, 17–25. [Google Scholar] [CrossRef]
  140. Punwani, D.; Pelz, B.; Yu, J.; Arva, N.C.; Schafernak, K.; Kondratowicz, K.; Makhija, M.; Puck, J.M. Coronin-1A: Immune Deficiency in Humans and Mice. J. Clin. Immunol. 2015, 35, 100–107. [Google Scholar] [CrossRef]
  141. Martorella, M.; Barford, K.; Winckler, B.; Deppmann, C.D. Emergent Role of Coronin-1a in Neuronal Signaling. Vitam. Horm. 2017, 104, 113–131. [Google Scholar]
  142. Tang, X.; Li, Q.; Li, L.; Jiang, J. Expression of Talin-1 in Endometriosis and Its Possible Role in Pathogenesis. Reprod. Biol. Endocrinol. 2021, 19, 42. [Google Scholar] [CrossRef]
  143. Zhao, Y.; Lykov, N.; Tzeng, C. Talin-1 Interaction Network in Cellular Mechanotransduction (Review). Int. J. Mol. Med. 2022, 49, 60. [Google Scholar] [CrossRef] [PubMed]
  144. Lu, F.; Zhu, L.; Bromberger, T.; Yang, J.; Yang, Q.; Liu, J.; Plow, E.F.; Moser, M.; Qin, J. Mechanism of Integrin Activation by Talin and Its Cooperation with Kindlin. Nat. Commun. 2022, 13, 2362. [Google Scholar] [CrossRef] [PubMed]
Toxins 15 00625 g001
Figure 1. Exosome characterization. (A) Protein profile of the negative control (RPMI), positive control (PMA), and experimental group (Cr-LAAO) samples by SDS-PAGE 12% (w/v). MW: molecular weight. Histogram of the particle profile in the supernatant of the RPMI (B), PMA (C), and Cr-LAAO (D) groups after ultracentrifugation using dynamic light scattering (DLS) technique employed to determine the nuclear dimensions of the nanoparticles using the Zetasizer Nano ZS system (Mallvern® Instrument, Malvern, UK). (E) Western blot for CD81 and CD63 using the supernatant of neutrophils (1 × 107) stimulated with PMA (500 ng/mL) for the positive control (C+), RPMI for the negative control (C−), and Cr-LAAO (100 μg/mL) after 3 h of incubation in a humidified atmosphere of CO2 (5%) at 37 °C.
Figure 1. Exosome characterization. (A) Protein profile of the negative control (RPMI), positive control (PMA), and experimental group (Cr-LAAO) samples by SDS-PAGE 12% (w/v). MW: molecular weight. Histogram of the particle profile in the supernatant of the RPMI (B), PMA (C), and Cr-LAAO (D) groups after ultracentrifugation using dynamic light scattering (DLS) technique employed to determine the nuclear dimensions of the nanoparticles using the Zetasizer Nano ZS system (Mallvern® Instrument, Malvern, UK). (E) Western blot for CD81 and CD63 using the supernatant of neutrophils (1 × 107) stimulated with PMA (500 ng/mL) for the positive control (C+), RPMI for the negative control (C−), and Cr-LAAO (100 μg/mL) after 3 h of incubation in a humidified atmosphere of CO2 (5%) at 37 °C.
Toxins 15 00625 g001
Toxins 15 00625 g002
Figure 2. Volcano Plot analysis of Cr-LAAO ̶ stimulated neutrophils. Important features selected by volcano plot with fold change threshold (x) and t-tests threshold (y). The pink circles represent features above the threshold. Note both fold changes and p values are log-transformed. The further its position away from the (0, 0), the more significant the feature is (A). PLS-DA analysis of differentially expressed proteins in response to Cr-LAAO treatment in cells (control group vs. LAAO group) (B). VIP score (Variable Importance in Projection score) represents the importance of each variable in the protein projection. The important factors identified by the PLS-DA analysis are listed in decreasing order of importance. VIP scores ≥ 1.7 were considered statistically significant. High VIP scores indicate a significant contribution of proteins to the separation between the control and Cr-LAAO groups. The boxes on the right indicate the relative concentration of the corresponding protein in each study group. Red boxes indicate higher protein abundance, while green boxes indicate lower abundance (C).
Figure 2. Volcano Plot analysis of Cr-LAAO ̶ stimulated neutrophils. Important features selected by volcano plot with fold change threshold (x) and t-tests threshold (y). The pink circles represent features above the threshold. Note both fold changes and p values are log-transformed. The further its position away from the (0, 0), the more significant the feature is (A). PLS-DA analysis of differentially expressed proteins in response to Cr-LAAO treatment in cells (control group vs. LAAO group) (B). VIP score (Variable Importance in Projection score) represents the importance of each variable in the protein projection. The important factors identified by the PLS-DA analysis are listed in decreasing order of importance. VIP scores ≥ 1.7 were considered statistically significant. High VIP scores indicate a significant contribution of proteins to the separation between the control and Cr-LAAO groups. The boxes on the right indicate the relative concentration of the corresponding protein in each study group. Red boxes indicate higher protein abundance, while green boxes indicate lower abundance (C).
Toxins 15 00625 g002
Toxins 15 00625 g003
Figure 3. Ontology analysis of proteins differentially expressed in exosomes from Cr-LAAO-stimulated neutrophils. Human neutrophils were stimulated with 100 µg/mL Cr-LAAO for 3 h. After incubation, the supernatant containing the exosomes was collected and subjected to ultracentrifugation (100,000× g) for 3 h. The exosomes were subjected to polyacrylamide gel electrophoresis for protein separation and subsequent proteomics analysis. Data referring to the biological process (A), molecular function (B), and cellular component (C) were analyzed using Panther software. Unique proteins are present in the Cr-LAAO experimental group when compared to the control group.
Figure 3. Ontology analysis of proteins differentially expressed in exosomes from Cr-LAAO-stimulated neutrophils. Human neutrophils were stimulated with 100 µg/mL Cr-LAAO for 3 h. After incubation, the supernatant containing the exosomes was collected and subjected to ultracentrifugation (100,000× g) for 3 h. The exosomes were subjected to polyacrylamide gel electrophoresis for protein separation and subsequent proteomics analysis. Data referring to the biological process (A), molecular function (B), and cellular component (C) were analyzed using Panther software. Unique proteins are present in the Cr-LAAO experimental group when compared to the control group.
Toxins 15 00625 g003
Toxins 15 00625 g004
Figure 4. Protein–protein interactions of differentially expressed proteins in neutrophils upon Cr-LAAO treatment. Data were generated using String software (https://string-db.org, accessed on 4 February 2022). Circles denote proteins, and straight lines illustrate interactions between these proteins. The thickness of the lines corresponds to the strength of associations.
Figure 4. Protein–protein interactions of differentially expressed proteins in neutrophils upon Cr-LAAO treatment. Data were generated using String software (https://string-db.org, accessed on 4 February 2022). Circles denote proteins, and straight lines illustrate interactions between these proteins. The thickness of the lines corresponds to the strength of associations.
Toxins 15 00625 g004
Table 1. Proteins differentially expressed in Cr-LAAO-stimulated neutrophils.
Table 1. Proteins differentially expressed in Cr-LAAO-stimulated neutrophils.
Fold Change
Protein DescriptionAccess CodeLAAO/ControlControl/LAAO
Alpha-actinin-2F6THM64.0756-
Myomesin-2P542963.3955-
ATP synthase subunit alpha, mitochondrialP257052.9427-
Myosin-2Q9UKX22.8325-
Alpha-actinin-2P356092.8138-
Myosin-1P128822.7773-
Myosin-binding protein C, slow-typeF8VZY02.6963-
Myosin-6P135332.6811-
Myosin-7P128832.6417-
ATP synthase subunit beta, mitochondrialP065762.5931-
Myosin-8P135352.5761-
Myosin-4Q9Y6232.5727-
Alpha-actinin-3A0A087WSZ22.4419-
Myosin light chain 1/3, skeletal muscle isoformP059762.3077-
Myosin-13Q9UKX32.2757-
ADP/ATP translocase 1P122352.2577-
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2H7C5W92.0930-
Putative elongation factor 1-alpha-like 3Q5VTE0-2.2892
LactotransferrinP02788-2.3342
Coronin-1AP31146-2.6324
MyeloperoxidaseP05164-2.866
Complement C3P01024-2.9114
Immunoglobulin heavy constant gamma 1A0A0A0MS08-2.9392
Tubulin beta-6 chainQ9BUF5-3.4374
Myosin-9P35579-3.5126
MyeloblastinP24158-3.5948
Inter-alpha-trypsin inhibitor heavy chain H3Q06033-4.0529
Triosephosphate isomeraseP60174-4.2686
Glycogen phosphorylase, liver formP06737-4.367
Tubulin beta-4A chainP04350-5.1224
Transitional endoplasmic reticulum ATPaseP55072-5.5079
Cathepsin GP08311-5.5802
Tubulin beta-4B chainP68371-5.9516
Tubulin beta chainP07437-6.5033
Tubulin alpha chainF5H5D3-6.8008
Filamin-AP21333-7.1256
Apolipoprotein B-100P04114-8.8368
Tubulin alpha-4A chainP68366-9.317
Pigment epithelium-derived factorP36955-9.9446
Talin-1Q9Y490-12.962
Adenylyl cyclase-associated protein 1Q01518-13.314
Table 2. Proteins differentially expressed in Cr-LAAO compared to PMA-stimulated in exosomes neutrophils.
Table 2. Proteins differentially expressed in Cr-LAAO compared to PMA-stimulated in exosomes neutrophils.
ProteinMechanismReference
Glucose-6-phosphate1-dehydrogenase; 6-phosphogluconate dehydrogenase;
glucose-6-phosphate isomerase; transketolase.		Involved in the pentose phosphate pathway and plays an important role in the generation of NADPH.[108,109,110,111,112]
desmoglein-1Key role in the structure and function of epithelial cells, like cell–cell adhesion.[113,114,115]
Myomesin 2Formation and maintenance of the structure of the sarcomere.[67,116]
Polyubiquitin CDirectly related to protein degradation through the proteasome.[117,118,119]
Serpine B12A protein involved in the downregulation of endopeptidase activity, providing protection to epithelial cells.[120]
Filamin COrganization and stabilization of the cytoskeleton, mainly in muscle cells.[121,122]
NebulinActs mainly in the regulation of muscle structure and function, it is crucial for the proper functioning of skeletal muscles.[123,124]
Leukotriene A4 hydrolasePlays a central role in the synthesis of leukotrienes, which are an important inflammatory mediator for immune response.[125,126]
Vitamin D binding proteinPlays a crucial role in the transport and regulation of vitamin D in the body.[127]
Cathelicidin antimicrobial peptidePlays a key role in host defense against microbial infections, including bacteria, viruses, fungi, and even parasites.[128,129]
FibronectinPlays multiple roles in cell adhesion, migration, wound healing, embryonic development, and immune response, produced by various cells, including fibroblasts, hepatocytes, endothelial cells, and muscle cells.[128,130]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Serrath, S.N.; Pontes, A.S.; Paloschi, M.V.; Silva, M.D.S.; Lopes, J.A.; Boeno, C.N.; Silva, C.P.; Santana, H.M.; Cardozo, D.G.; Ugarte, A.V.E.; et al. Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action. Toxins 2023, 15, 625. https://doi.org/10.3390/toxins15110625

AMA Style

Serrath SN, Pontes AS, Paloschi MV, Silva MDS, Lopes JA, Boeno CN, Silva CP, Santana HM, Cardozo DG, Ugarte AVE, et al. Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action. Toxins. 2023; 15(11):625. https://doi.org/10.3390/toxins15110625

Chicago/Turabian Style

Serrath, Suzanne N., Adriana S. Pontes, Mauro V. Paloschi, Milena D. S. Silva, Jéssica A. Lopes, Charles N. Boeno, Carolina P. Silva, Hallison M. Santana, Daniel G. Cardozo, Andrey V. E. Ugarte, and et al. 2023. "Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action" Toxins 15, no. 11: 625. https://doi.org/10.3390/toxins15110625

APA Style

Serrath, S. N., Pontes, A. S., Paloschi, M. V., Silva, M. D. S., Lopes, J. A., Boeno, C. N., Silva, C. P., Santana, H. M., Cardozo, D. G., Ugarte, A. V. E., Magalhães, J. G. S., Cruz, L. F., Setubal, S. S., Soares, A. M., Cavecci-Mendonça, B., Santos, L. D., & Zuliani, J. P. (2023). Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action. Toxins, 15(11), 625. https://doi.org/10.3390/toxins15110625

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop